Skip to main content
Clinical Trials/NCT05187312
NCT05187312
Recruiting
Not Applicable

Research Registry for Endoscopic Treatment and Diagnostics

Region Stockholm1 site in 1 country1,000 target enrollmentJanuary 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cholangiocarcinoma
Sponsor
Region Stockholm
Enrollment
1000
Locations
1
Primary Endpoint
Diagnostic yield
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract

Registry
clinicaltrials.gov
Start Date
January 14, 2022
End Date
January 14, 2032
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Clinical indication for endoscopic intervention/procedure

Exclusion Criteria

  • No informed consent
  • Age \<18 years

Outcomes

Primary Outcomes

Diagnostic yield

Time Frame: 1-year follow up

Diagnostic yield after tissue sampling

Adverse events

Time Frame: 30-days and 60-days post-procedure

Incidence of Adverse events following endoscopic procedures. Measured as percentage of individuals with an adverse event

Study Sites (1)

Loading locations...

Similar Trials